MAC Clinical Research is proud to support Initiator Pharma as the full-service CRO partner for their upcoming Phase 2a clinical
We are proud to announce the successful completion of Kariya Pharmaceuticals’ Phase I clinical trial for KP405, a brain-penetrant GLP-1/GIP
The UK’s clinical research environment is changing, and quickly. Recent updates from the Medicines and Healthcare products Regulatory Agency (MHRA)
Contract Research Organisations (CROs) are often associated with the operational side of clinical trials: patient recruitment, data management, site monitoring
We are pleased to share that the first patient has now been dosed in a Phase 2 clinical trial –
If you’re a researcher with a promising therapeutic, device or intervention, there comes a point where someone suggests taking it
MAC Clinical Research is pleased to announce the successful dosing of the first participant in a Phase 2 clinical study
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase
MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient
At MAC Clinical Research, we believe in transparency, collaboration, and driving conversations that matter in clinical research. Over the past
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
